Remove Dosage Remove Packaging Remove Vaccines
article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Kennedy Jr.

article thumbnail

3 of the year’s most notable FDA nods

PharmaVoice

Other PrEP regimens on the market require daily oral dosages or shots every few months, but the latest version is only administered twice a year. A long-time leader in vaccines, the U.K. The FDA approved the updated formulation, which will be sold under the brand name Yeztugo, earlier this month.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Achieving Targeted Delivery with Nanoscale Systems

PharmaTech

All these challenges tend to lead to high costs for therapeutics and vaccines leveraging nanoscale drug delivery systems. The improved targeting capability of nanoscale delivery systems also leads to improved activation of immune cells in cancer vaccines. link] org/10.1016/j.jddst.2023.104724

article thumbnail

Why most extractables & leachables studies fail regulatory review-and how to fix them

Express Pharma

This article explores why E&L studies go wrong and how to build a submission-ready package from protocol to final report. How to get it right -A practical framework Start with a Risk Assessment: Map out materials, dosage form, route of administration, and expected interactions. Many Indian companies skip this step.

article thumbnail

MilliporeSigma and Simtra Launch Five-Year Agreement for Drug Substance, Drug Manufacturing Services

PharmaTech

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

article thumbnail

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

Last month, European Commission approved the new subcutaneous (SC) formulation of Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) with a dosage strength of 600 mg/vial, expanding treatment options for various adult solid tumours. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

article thumbnail

N-FIS was developed to address a critical challenge in healthcare—needle phobia

Express Pharma

Research has reported that fear of needles constitutes about 20-50 per cent among children and 20-30 per cent among adults globally; often leading to missed vaccinations and delayed treatments. How does the company collaborate with pharma and vaccine companies to optimise efficacy of medicines with this delivery system?